INTEGRA Biosciences and Viaflo Corporation Join Forces
News Aug 18, 2009
The combining of the two companies provides for strong mutual benefits. INTEGRA Biosciences will be receiving direct access to the important US Market through the Viaflo sales network. INTEGRA Biosciences also receives access to a complete line of new and innovative handheld pipetting systems and associated plastic disposables. Viaflo will receive strong representation and access to European and global markets through INTEGRA Biosciences and their large network of specialist distributors. In the USA - Viaflo will also benefit from selling the complimentary, well recognised, and established INTEGRA Biosciences product portfolio. The INTEGRA Biosciences and Viaflo products complement each other perfectly.
The new group, in the last 2 years has translated customer needs into the introduction of many new innovative and reliable products. With specialists in sales, marketing, research, development and manufacturing it maintains close relations and collaborations with customers worldwide for the purpose of providing cutting edge technologies to the health care industry.
As a result of constant growth achieved over recent years, INTEGRA Biosciences has announced that it will also move from its current location into a larger new modern industrial building in Zizers, Switzerland.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018